Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:51 am
Author: Getaka|Social: XLinkedIn

TTK Healthcare Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹681.70Overvalued by 13.05%vs CMP ₹784.00

P/E (15.9) × ROE (6.9%) × BV (₹768.00) × DY (1.28%)

₹626.00Overvalued by 20.15%vs CMP ₹784.00
MoS: -25.2% (Negative)Confidence: 52/100 (Moderate)Models: 1 Under, 3 Fair, 6 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹733.7221%Fair (-6.4%)
Graham NumberEarnings₹857.0715%Fair (+9.3%)
Earnings PowerEarnings₹995.0110%Under (+26.9%)
DCFCash Flow₹622.5113%Over (-20.6%)
Net Asset ValueAssets₹768.427%Fair (-2%)
EV/EBITDAEnterprise₹285.418%Over (-63.6%)
Dividend DiscountDividends₹147.848%Over (-81.1%)
Earnings YieldEarnings₹425.107%Over (-45.8%)
ROCE CapitalReturns₹348.497%Over (-55.5%)
Revenue MultipleRevenue₹567.285%Over (-27.6%)
Consensus (10 models)₹626.00100%Overvalued
Key Drivers: Wide model spread (₹148–₹995) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 7.6%

*Investments are subject to market risks

Investment Snapshot

56
TTK Healthcare Ltd scores 56/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health70/100 · Strong
ROCE 9.3% AverageROE 6.9% AverageD/E 0.06 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 74.6% StableShareholders up 39% Retail surge
Earnings Quality60/100 · Moderate
OPM stable around 5% SteadyWorking capital: 48 days (improving) Efficient
Quarterly Momentum40/100 · Moderate
Revenue (4Q): 5% YoY FlatProfit (4Q): -29% YoY Declining
Industry Rank45/100 · Moderate
P/E 15.9 vs industry 53.8 Cheaper than peersROCE 9.3% vs industry 16.4% Below peersROE 6.9% vs industry 15.2% Below peers3Y sales CAGR: 10% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:51 am

Market Cap 1,107 Cr.
Current Price 784
Intrinsic Value₹626.00
High / Low 1,402/735
Stock P/E15.9
Book Value 768
Dividend Yield1.28 %
ROCE9.26 %
ROE6.89 %
Face Value 10.0
PEG Ratio2.08

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for TTK Healthcare Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
TTK Healthcare Ltd 1,107 Cr. 784 1,402/73515.9 7681.28 %9.26 %6.89 % 10.0
Ind-Swift Laboratories Ltd 1,128 Cr. 138 152/67.223.8 1600.00 %0.78 %0.18 % 10.0
Venus Remedies Ltd 1,151 Cr. 861 950/28615.1 4450.00 %11.1 %7.16 % 10.0
Hester Biosciences Ltd 1,162 Cr. 1,366 2,350/1,23928.4 3970.51 %9.71 %9.18 % 10.0
Syncom Formulations (India) Ltd 1,050 Cr. 11.2 23.5/10.215.2 4.000.00 %18.6 %15.5 % 1.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of TTK Healthcare Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 183180202186184181208198205190226204209
Expenses 174165192176179169201190197178224198202
Operating Profit 815101051278812357
OPM % 5%8%5%5%3%7%3%4%4%6%1%3%3%
Other Income 12121516161637181813181910
Interest 1111011111111
Depreciation 3333332222222
Profit before tax 16232122182441232322182114
Tax % 26%27%24%26%27%25%23%26%26%26%26%4%25%
Net Profit 12171616131832171716132011
EPS in Rs 8.4911.9911.0911.339.1212.9322.3512.1711.8411.439.2014.437.45

Last Updated: February 3, 2026, 7:16 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 6:41 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 416483519528578628646476599725753801830
Expenses 396453478489535578617457577694715767803
Operating Profit 20304038435028192231373527
OPM % 5%6%8%7%7%8%4%4%4%4%5%4%3%
Other Income 67668892842643638560
Interest 3433533235333
Depreciation 367121515141313131389
Profit before tax 2026362930391932486578410875
Tax % 37%39%36%36%40%38%37%-44%13%3%25%25%
Net Profit 121623191824124642640638260
EPS in Rs 15.9520.8129.1924.1312.8617.258.7232.8729.43452.7244.4757.7942.51
Dividend Payout % 25%22%17%21%39%29%34%18%34%2%22%17%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)33.33%43.75%-17.39%-5.26%33.33%-50.00%283.33%-8.70%1423.81%-90.16%30.16%
Change in YoY Net Profit Growth (%)0.00%10.42%-61.14%12.13%38.60%-83.33%333.33%-292.03%1432.51%-1513.97%120.31%

TTK Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:5%
5 Years:4%
3 Years:10%
TTM:8%
Compounded Profit Growth
10 Years:16%
5 Years:42%
3 Years:22%
TTM:6%
Stock Price CAGR
10 Years:2%
5 Years:20%
3 Years:9%
1 Year:-34%
Return on Equity
10 Years:23%
5 Years:26%
3 Years:29%
Last Year:7%

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: December 4, 2025, 2:08 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 8888141414141414141414
Reserves 991101281502192372352813169399871,0511,071
Borrowings 32423823472930192227232427
Other Liabilities 102115128104127136152180207189183192184
Total Liabilities 2402753032854074164314945591,1701,2061,2811,296
Fixed Assets 5452106991109889858071758178
CWIP 24610129003100
Investments 001099139131513131112
Other Assets 1841771851772883043253954631,0831,1181,1891,205
Total Assets 2402753032854074164314945591,1701,2061,2811,296

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 133937182517209645-25-5-4
Cash from Investing Activity + -15-49-275-2210-13-77-30322820
Cash from Financing Activity + 23-11-23-7-31-10-17-10-12-22-18
Net Cash Flow 0-7-00-4-4-425-62-2
Free Cash Flow -3-102112211389542-36-156
CFO/OP 84%176%122%67%84%62%108%391%248%-28%54%68%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-12.00-12.002.0015.00-4.0021.00-2.000.000.004.0014.0011.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 343433243547434633464241
Inventory Days 64626665807710112310289105107
Days Payable 565053100130101121170134116110106
Cash Conversion Cycle 414646-11-162223-21193643
Working Capital Days -24-31-38-24-30-6-3-32-2844948
ROCE %17%20%23%18%15%15%8%6%8%10%9%9%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%
FIIs 2.38%2.40%1.85%1.85%1.85%1.87%1.90%1.90%1.90%1.89%1.90%1.89%
DIIs 2.99%3.27%3.23%3.13%1.14%1.14%1.14%1.14%1.14%1.18%1.18%1.08%
Public 20.07%19.76%20.37%20.46%22.45%22.44%22.39%22.39%22.40%22.37%22.37%22.46%
No. of Shareholders 15,81816,10915,67216,65117,22116,93015,76215,78015,89916,11216,13422,481

Shareholding Pattern Chart

No. of Shareholders

TTK Healthcare Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Axis ELSS Tax Saver Fund 172,386 0.08 25.52172,3862025-04-22 15:56:520%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 57.7944.47452.7229.4332.87
Diluted EPS (Rs.) 57.7944.47452.7229.4332.87
Cash EPS (Rs.) 63.6953.71461.7938.3442.08
Book Value[Excl.RevalReserv]/Share (Rs.) 750.61705.23671.59230.16205.40
Book Value[Incl.RevalReserv]/Share (Rs.) 753.73708.35674.71233.28208.52
Dividend / Share (Rs.) 10.0010.0010.0010.006.00
Revenue From Operations / Share (Rs.) 567.22532.75513.16424.08336.91
PBDIT / Share (Rs.) 75.0770.7256.3927.0120.70
PBIT / Share (Rs.) 69.1861.4847.3318.1111.49
PBT / Share (Rs.) 76.6759.5343.6217.5816.01
Net Profit / Share (Rs.) 57.7944.47452.7229.4332.87
PBDIT Margin (%) 13.2313.2710.986.366.14
PBIT Margin (%) 12.1911.549.224.263.41
PBT Margin (%) 13.5111.178.504.144.75
Net Profit Margin (%) 10.188.3488.226.949.75
Return on Networth / Equity (%) 7.696.3067.4112.7816.00
Return on Capital Employeed (%) 9.138.646.977.565.31
Return On Assets (%) 6.375.2354.677.449.39
Total Debt / Equity (X) 0.020.020.020.060.06
Asset Turnover Ratio (%) 0.640.630.831.141.03
Current Ratio (X) 5.235.505.062.031.99
Quick Ratio (X) 4.725.014.661.681.61
Inventory Turnover Ratio (X) 7.801.912.231.921.38
Dividend Payout Ratio (NP) (%) 17.3022.482.2020.389.12
Dividend Payout Ratio (CP) (%) 15.7018.612.1615.657.12
Earning Retention Ratio (%) 82.7077.5297.8079.6290.88
Cash Earning Retention Ratio (%) 84.3081.3997.8484.3592.88
Interest Coverage Ratio (X) 31.9136.2715.2111.7917.10
Interest Coverage Ratio (Post Tax) (X) 21.3823.819.535.9517.77
Enterprise Value (Cr.) 926.981342.13639.44918.42488.79
EV / Net Operating Revenue (X) 1.161.780.881.531.03
EV / EBITDA (X) 8.7413.438.0324.0616.71
MarketCap / Net Operating Revenue (X) 2.112.782.011.961.47
Retention Ratios (%) 82.6977.5197.7979.6190.87
Price / BV (X) 1.592.101.543.602.41
Price / Net Operating Revenue (X) 2.112.782.011.961.47
EarningsYield 0.040.020.430.030.06

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

TTK Healthcare Ltd. is a Public Limited Listed company incorporated on 21/05/1958 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24231TN1958PLC003647 and registration number is 003647. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 801.49 Cr. and Equity Capital is Rs. 14.13 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsNo 6, Cathedral Road, Chennai (Madras) Tamil Nadu 600086Contact not found
Management
NamePosition Held
Mr. T T RaghunathanExecutive Chairman
Mr. S KalyanaramanManaging Director & CEO
Mr. K ShankaranDirector
Mr. R K TulshanDirector
Dr. T T MukundDirector
Mr. N Ramesh RajanIndependent Director
Mr. V RanganathanIndependent Director
Mr. Murali NeelakantanIndependent Director
Mrs. Subashree AnantkrishnanIndependent Director
Mrs. Hastha ShivaramakrishnanIndependent Director

FAQ

What is the intrinsic value of TTK Healthcare Ltd and is it undervalued?

As of 10 April 2026, TTK Healthcare Ltd's intrinsic value is ₹626.00, which is 20.15% lower than the current market price of ₹784.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (6.89 %), book value (₹768), dividend yield (1.28 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of TTK Healthcare Ltd?

TTK Healthcare Ltd is trading at ₹784.00 as of 10 April 2026, with a FY2026-2027 high of ₹1,402 and low of ₹735. The stock is currently near its 52-week low. Market cap stands at ₹1,107 Cr..

How does TTK Healthcare Ltd's P/E ratio compare to its industry?

TTK Healthcare Ltd has a P/E ratio of 15.9, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is TTK Healthcare Ltd financially healthy?

Key indicators for TTK Healthcare Ltd: ROCE of 9.26 % is on the lower side compared to the industry average of 16.35%; ROE of 6.89 % is below ideal levels (industry average: 15.16%). Dividend yield is 1.28 %.

Is TTK Healthcare Ltd profitable and how is the profit trend?

TTK Healthcare Ltd reported a net profit of ₹82 Cr in Mar 2025 on revenue of ₹801 Cr. Compared to ₹42 Cr in Mar 2022, the net profit shows an improving trend.

Does TTK Healthcare Ltd pay dividends?

TTK Healthcare Ltd has a dividend yield of 1.28 % at the current price of ₹784.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in TTK Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports